Research & Evidence

Trial design, systematic reviews, medical statistics, and guideline updates.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Research & Evidence


washingtonpost.com > health > 08/26/2026 > fda-approves-landmark-pancreatic-cancer-drug-daraxonrasib

FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives

2+ week, 5+ day ago   (126+ words) Breaking news and analysis on politics, business, world, national news, entertainment and more. In-depth DC, Virginia, Maryland news coverage including traffic, weather, crime, education, restaurant reviews and more. In trials, Revolution Medicines’ daraxonrasib nearly doubled average survival times for one…...


washingtonpost.com > opinions > 08/25/2026 > montana-is-paving-way-unapproved-medical-treatments

Opinion | An unlikely state makes a bold bet on experimental medical treatments

2+ week, 6+ day ago   (93+ words) The Washington Post New Montana right-to-try law licenses centers for therapies not fully approved by FDA. Vicki Norton is a partner at the Duane Morris law firm, where she co-leads the life sciences team. My 84-year-old mother succumbed to pancreatic…...


washingtonpost.com > health > 08/23/2026 > meet-two-patients-who-tested-one-cancers-most-promising-breakthroughs

What it was like to go through a trial that could revolutionize cancer treatment

3+ week, 1+ day ago   (79+ words) The Washington Post Scientists said the drug trial of the treatment for melanoma could be the beginning of a transformation in care. After Mark Orwig had a melanoma tumor removed from his cheek in 2023, he began to worry about the…...